RT Journal Article
SR Electronic
A1 Boltz, Kathy
T1 Biochemical Control of Acromegaly Continued in PAOLA Trial Extension
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 4
SP 10
OP 10
DO 10.1177/1559897715583811
UL http://mdc.sagepub.com/content/15/4/10.2.abstract
AB This extension study of the phase 3 PAOLA trial found that pasireotide LAR may be a viable, long-term treatment option for patients with acromegaly that is inadequately controlled with first-generation somatostatin analogues. Biochemical control of growth hormone and normalized insulin-like growth factor 1 continued through extension week 28.